The global burden of mental disorders

American Journal of Public Health

Volumn 89, Issue 9, 1999, Pages 1315-1318

  Üstün, T Bedirhan ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; HUMAN; MENTAL DISEASE; PATIENT COUNSELING; PSYCHOSOCIAL CARE; PUBLIC HEALTH; REVIEW; WORLD HEALTH ORGANIZATION;

EID: 0039887964     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.89.9.1315     Document Type: Review

References (24)

1. Murray CJL, Lopez AD. The Global Burden of Disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge, Mass: Harvard University Press; 1996.
2. World Health Organization. The World Health Report 1999 - Making a Difference. Geneva, Switzerland: World Health Organization; 1999.
3. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause, 1990-2020: Global Burden of Disease Study. Lancet. 1997;349:1498-1504.
4. Omran AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q. 1971;49: 509-538.
5. Kalache A. Demographic transition poses a challenge to societies worldwide. Trop Med Int Health. 1997;2:925-926.
6. Manton KG, Stallard E, Corder L. Changes in the age dependence of mortality and disability: cohort and other determinants. Demography. 1997;34:135-157.
7. World Bank. World Development Report 1993 - Investing in Health. Oxford, England: Oxford University Press; 1993.
8. Andreasen NC. Linking mind and brain in the study of mental illness: a project for a scientific psychopathology. Science. 1997;275: 1586-1593.
9. Mazziotta JC. Mapping mental illness. A new era. Arch Gen Psychiatry. 1996;53:574-576.
10. McGuffin, Martin N. Behaviour and genes. BMJ. 1999;319:37-40
11. Berman RM, Narasimhan M, Miller HL, et al. Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker? Arch Gen Psychiatry. 1999; 56:395-403.
12. Lehman AF, Steinwachs DM. At issue: translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophr Bull. 1998; 24:1-10.
13. Spigset O, Martensson B. Drug treatment of depression. BMJ. 1999;318:1188-1191.
14. Wells KB. The design of Partners in Care: evaluating the cost-effectiveness of improving care for depression in primary care. Soc Psychiatry Psychiatr Epidemiol. 1999;34:20-29.
15. Von Korff M, Katon W, Bush T, et al. Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression. Psychosom Med. 1998;60:143-149.
16. Malt UF, Robak OH, Madsbu HP, Bakke O, Loeb M. The Norwegian naturalistic treatment study of depression in general practice (NORDEP)-I: randomised double blind study. BMJ. 1999;318:1180-1184.
17. Jamison DT. Disease control priorities in developing countries: an overview. In: Jamison DT, Mosley WH, Measham AR, Bobadilla JL, eds. Disease Control Priorities in Developing Countries. Oxford, England: Oxford University Press; 1993:3-34.
18. Bobadilla JL, Cowley P, Musgrove P, Saxenian H. Design, content and financing of an essential national package of health services. Bull World Health Organ. 1994;72:653-662.
19. Weissman MM, Üstün TB, Eisenberg L, et al. Epidemiologic strategies to address world health problems in underserved populations: task force report. Int J Ment Health. In press.
20. Kessler RC. The World Health Organization International Consortium in Psychiatric Epidemiology (ICPE): initial work and future directions - the NAPE Lecture 1998. Nordic Association for Psychiatric Epidemiology. Acta Psychiatr Scand. 1999;1:2-9.
21. Barker DJ. The Wellcome Foundation Lecture 1994: the fetal origins of adult disease. Proc R Soc Lond B Biol Sci. 1995;262:37-43.
22. Neugebauer R, Hoek HW, Susser E. Prenatal exposure to wartime famine and antisocial personality disorder in adult offspring. JAMA. In press.
23. Hemingway H, Marmot M. Psychosocial factors in the aetiology and prognosis of coronary heart disease: systematic review of prospective cohort studies. BMJ. 1999;318:1460-1467.
24. World Health Organization. ICIDH-2: International Classification of Functioning and Disability. Beta-2 Draft for Field Trials. Geneva, Switzerland: World Health Organization; 1999.